Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 022334/0831 | |
| Pages: | 6 |
| | Recorded: | 03/03/2009 | | |
Attorney Dkt #: | 50233-US |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
01/10/2012
|
Application #:
|
12301690
|
Filing Dt:
|
11/20/2008
|
Publication #:
|
|
Pub Dt:
|
01/28/2010
| | | | |
Title:
|
4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]-benzamide for treatment of melanoma
|
|
Assignee
|
|
|
LICHTSTRASSE 35 |
BASEL, SWITZERLAND 4056 |
|
Correspondence name and address
|
|
LINDA ADAMS
|
|
NOVARTIS PHARMACEUTICALS CORP.
|
|
ONE HEALTH PLAZA
|
|
EAST HANOVER, NJ 07936
|
Search Results as of:
06/06/2024 08:01 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|